SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
HIV Immunology and Vaccines
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
12 of
12
|
Safety Profile and Immunogenicity of a Phase I Clinical Trial Using Germline-Targeting Trimer GT1.1 (ABSTRACT
100)
Karlijn van der Straten
Academic Medical Center, Amsterdam, Netherlands
Vaccine Combining Slow-Delivery and Follicle-Targeting Improve Humoral and Germinal Center Responses (ABSTRACT
101)
Y. Jason Zhang
Massachusetts Institute of Technology, Cambridge, MA, USA
Multi-Specificity Is a Common Trait of HIV-1 Broad Neutralizing Capacity (ABSTRACT
102)
Alexandra Trkola
University of Zurich, Zurich, Switzerland
CD4 Binding Site Glycan-Deficient SHIVs Elicit Broadly Neutralizing Antibodies in Rhesus Macaques (ABSTRACT
103)
Daniel J. Morris
University of Pennsylvania, Philadelphia, PA, USA
QUESTIONS AND ANSWERS (Part 1)
MHC-E Presentation Mediates SIV-Specific NK Cell Responses in SIV-Infected Rhesus Macaques (ABSTRACT
104)
Philippe Rascle
Duke University, Durham, NC, USA
[18F]F-AraG PET Imaging Reveals Unique Tissue T-Cell Activation Patterns Across HIV Infection States (ABSTRACT
105)
Timothy J. Henrich
University of California San Francisco, San Francisco, CA, USA
Biomarker Signatures in Phase Ib Study With PD-1 Inhibitor, Budigalimab, in PLWH Undergoing ATI (ABSTRACT
106)
Preethi Krishnan
AbbVie, Inc, North Chicago, IL, USA
Live Single-Cycle SARS-CoV-2 Vaccine Elicits High Protection and Sterilizing Immunity (ABSTRACT
107)
Fabian Otte
University of Basel, Basel, Switzerland
QUESTIONS AND ANSWERS (Part 2)
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
12 of
12
|
